NLRP3 and atrial fibrillation: We suggest one potential mechanism through which gut inflammation leads to AF, whereby activation of the NLRP3 inflammasome due to gut microbiota dysfunction stimulates interleukin‐18 secretion, in turn elevating AF risk.